Related Experiment Video

Updated: Aug 15, 2026

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

Overcoming the inflammatory toxicity of cationic gene vectors

Yadi Tan1, Leaf Huang

  • 1Department of Pharmacology, School of Medicine, University of Pittsburgh, PA 15213, USA.

Journal of Drug Targeting
|June 21, 2002
PubMed

Insights

Synthetic gene vectors using cationic lipids and polymers show promise but face challenges due to inflammatory toxicity. This review explores strategies to mitigate these toxic effects for improved clinical applications.

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Nanomedicine

Background:

  • Cationic lipid- and polymer-based vectors are extensively studied synthetic gene delivery systems.
  • These vectors have demonstrated utility in animal models and early clinical trials.
  • Inflammatory toxicity remains a significant hurdle limiting their clinical advancement.

Purpose of the Study:

  • To review observations and mechanisms of inflammatory toxicity associated with cationic gene vectors.
  • To summarize current strategies for overcoming this toxicity.
  • To provide insights for the development of safer gene delivery systems.

Main Methods:

  • Literature review of studies on cationic gene vectors.
  • Analysis of reported inflammatory responses and their underlying mechanisms.
  • Compilation and categorization of strategies aimed at reducing toxicity.

Main Results:

  • Identified key factors contributing to the inflammatory toxicity of cationic vectors.
  • Detailed the molecular mechanisms driving these inflammatory responses.
  • Highlighted diverse approaches, including vector modification and co-administration, to mitigate toxicity.

Conclusions:

  • Overcoming inflammatory toxicity is crucial for the clinical translation of cationic gene vectors.
  • A multi-faceted approach addressing vector design and biological interactions is necessary.
  • Further research into targeted delivery and immunomodulation can enhance safety and efficacy.

More Related Videos

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery10:00

Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery

Published on: February 17, 2026

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...